DNA Vaccine Market By Source (Humans, Animals, Others), by Technology (pDNA delivery technology, pDNA vaccines technology), by Application (Human diseases, Veterinary diseases), Industry Trends, Estimation & Forecast, 2017 - 2025

Check Today's Best Price

$3500 Buy Now
DNA Vaccine Market is expected to grow with a CAGR of 40% during the forecast period of 2018 to 2025.
  • Market Overview:

    Technological advancements in the medical sector have led to the advent of third generation vaccines such as DNA, viral/bacterial vectored, and autologous proteins. DNA vaccine is an emerging vaccine type having several benefits such as usage of multiple genes to enhance immunity, specific targeting, and low risk rates as compared to the traditional vaccines. However, the translation of these benefits into actual clinical applications is still in pipeline and is expected to render lucrative opportunities to the market players during the upcoming years. Several clinical and preclinical trials are under process due to which, till date, only a small portion of the DNA vaccines has entered into the commercial market.

    The emergence of nouveau biotechnology and nanotechnology trends such as electroporation, novel molecular adjuvant technologies, and DNA prime-adenovector boost are fuelling the development rate of DNA vaccines. In terms of region, the developed nations are expected to gain a higher market share as compared to the developing nations, owing to the low penetration of DNA vaccines in the developing nations. The absence of fixed regulatory systems and low investment in modern medical therapies are anticipated to create hurdles in the growth of global DNA vaccine market.

    The report provides detailed qualitative and quantitative analysis of the DNA vaccine market. Market size and forecast in terms of value and volume has been provided for the period – (2017–2025) for the segments namely source, technology and application in each of the major regions.

    DNA Vaccine Market Segmentation

    By Source
    •Humans
    •Animals
    •Others

    By Technology
    •pDNA delivery technology
    •pDNA vaccines technology
    By Application
    •Human diseases
    •Veterinary diseases

    By Geography

    •North America
    oU.S.
    oCanada
    oMexico

    •Europe
    oU.K.
    oFrance
    oGermany
    oItaly
    oSpain
    oRest of Europe

    •Asia-Pacific
    oChina
    oJapan
    oIndia
    oKorea
    oRest of APAC

    •South America
    oBrazil
    oRest of South America

    •Rest of the World
    oMiddle East
    oAfrica

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources
    CHAPTER 2. DNA VACCINE MARKET OVERVIEW
    2.1. DNA VACCINE MARKET INTRODUCTION
    2.2. GLOBAL DNA VACCINE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1. Global DNA Vaccine Production (VOLUME) and Growth Rate (%), (2017-2025)
    2.3. GLOBAL DNA VACCINE MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1. Global DNA Vaccine Capacity (VOLUME) and Growth Rate (%), (2017-2025)
    2.4. GLOBAL DNA VACCINE MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1. Global DNA Vaccine Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5. GLOBAL DNA VACCINE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1. Global DNA Vaccine Consumption (VOLUME) and Growth Rate (%), (2017-2025)
    CHAPTER 3. GLOBAL DNA VACCINE MARKET BY SOURCE, 2017-2025
    3.1. HUMANS
    3.2. ANIMALS
    3.3. OTHERS
    3.4. GLOBAL DNA VACCINE MARKET REVENUE BY SOURCE, 2017-2025
    3.4.1. Global DNA Vaccine Market Revenue (Million USD) and Share (%) By Source, 2017-2025
    3.4.2. Humans Market Revenue and Growth Rate, 2017-2025
    3.4.3. Animals Market Revenue and Growth Rate, 2017-2025
    3.4.4. Others Market Revenue and Growth Rate, 2017-2025
    3.5. GLOBAL DNA VACCINE MARKET PRODUCTION BY SOURCE, 2017-2025
    3.5.1. Global DNA Vaccine Market Production (Volume) and Share (%) By Source, 2017-2025
    3.5.2. Humans Market Production and Growth Rate, 2017-2025
    3.5.3. Animals Market Production and Growth Rate, 2017-2025
    3.5.4. Others Market Production and Growth Rate, 2017-2025
    CHAPTER 4. GLOBAL DNA VACCINE MARKET BY APPLICATION, 2017-2025
    4.1. HUMAN DISEASES
    4.2. VETERINARY DISEASES
    4.3. GLOBAL DNA VACCINE MARKET REVENUE BY APPLICATION, 2017-2025
    4.3.1. Global DNA Vaccine Market Revenue (Million USD) and Share (%) By Application, 2017-2025
    4.3.2. Human diseases Market Revenue and Growth Rate, 2017-2025
    4.3.3. Veterinary diseases Market Revenue and Growth Rate, 2017-2025
    4.4. GLOBAL DNA VACCINE MARKET CONSUMPTION BY APPLICATION, 2017-2025
    4.4.1. Global DNA Vaccine Market Consumption (Volume) and share (%) By Application, 2017-2025
    4.4.2. Human diseases Market Consumption and Growth Rate, 2017-2025
    4.4.3. Veterinary diseases Market Consumption and Growth Rate, 2017-2025
    CHAPTER 5. GLOBAL DNA VACCINE MARKET BY TECHNOLOGY, 2017-2025
    5.1. PDNA DELIVERY TECHNOLOGY
    5.2. PDNA VACCINES TECHNOLOGY
    CHAPTER 6. GLOBAL DNA VACCINE MARKET BY REGION, 2017-2025
    6.1. NORTH AMERICA
    6.1.1. U.S.
    6.1.2. Canada
    6.1.3. Mexico
    6.2. EUROPE
    6.2.1. U.K.
    6.2.2. France
    6.2.3. Germany
    6.2.4. Italy
    6.2.5. Spain
    6.2.6. Rest of Europe
    6.3. ASIA PACIFIC
    6.3.1. China
    6.3.2. Japan
    6.3.3. India
    6.3.4. Korea
    6.3.5. Rest of APAC
    6.4. SOUTH AMERICA
    6.4.1. Brazil
    6.4.2. Rest of South America
    6.5. REST OF THE WORLD
    6.5.1. Middle East
    6.5.2. Africa
    6.6. GLOBAL DNA VACCINE MARKET REVENUE BY REGION, 2017-2025
    6.6.1. Global DNA Vaccine Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    6.6.2. North America Market Revenue and Growth Rate, 2017-2025
    6.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    6.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    6.6.5. South America Market Revenue and Growth Rate, 2017-2025
    6.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
    CHAPTER 7. GLOBAL DNA VACCINE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    7.1. GLOBAL DNA VACCINE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
    7.1.1. Global DNA Vaccine Market Production (Volume) and Share (%) By Region, 2017-2025
    7.1.2. Global DNA Vaccine Market Consumption (Volume) and Share (%) By Region, 2017-2025
    7.1.3. North America Market Production and Consumption, 2017-2025
    7.1.4. Europe Market Production and Consumption, 2017-2025
    7.1.5. Asia Pacific Market Production and Consumption, 2017-2025
    7.1.6. South America Market Production and Consumption, 2017-2025
    7.1.7. Rest of the World Market Production and Consumption, 2017-2025
    CHAPTER 8. MARKET DETERMINANTS
    8.1. MARKET DRIVERS
    8.2. MARKET RESTRAINTS
    8.3. MARKET OPPORTUNITIES
    8.4. MARKET DETERMINANTS RADAR CHART
    CHAPTER 9. GLOBAL DNA VACCINE MARKET COMPETITION BY MANUFACTURERS
    9.1. GLOBAL DNA VACCINE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    9.1.1. Global DNA Vaccine Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
    9.2. GLOBAL DNA VACCINE REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    9.2.1. Global DNA Vaccine Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    9.3. DNA VACCINE MARKET COMPETITIVE SITUATION AND TRENDS
    9.3.1. DNA Vaccine Market Share (%) of Top 3 Manufacturers
    9.3.2. DNA Vaccine Market Share (%) of Top 5 Manufacturers
    CHAPTER 10. GLOBAL DNA VACCINE MANUFACTURERS ANALYSIS
    10.1. VICAL INC.
    10.1.1. Business Overview
    10.1.2. Company Basic Information
    10.1.3. DNA Vaccine Product Details
    10.1.4. Vical Inc. DNA Vaccine Production, Revenue and Gross Margin
    10.2. NOVARTIS ANIMAL HEALTH
    10.2.1. Business Overview
    10.2.2. Company Basic Information
    10.2.3. DNA Vaccine Product Details
    10.2.4. Novartis Animal Health DNA Vaccine Production, Revenue and Gross Margin
    10.3. INOVIO BIOMEDICAL CORP.
    10.3.1. Business Overview
    10.3.2. Company Basic Information
    10.3.3. DNA Vaccine Product Details
    10.3.4. Inovio Biomedical Corp. DNA Vaccine Production, Revenue and Gross Margin
    10.4. DENDREON CORPORATION
    10.4.1. Business Overview
    10.4.2. Company Basic Information
    10.4.3. DNA Vaccine Product Details
    10.4.4. Dendreon Corporation DNA Vaccine Production, Revenue and Gross Margin
    10.5. ASTELLAS PHARMA
    10.5.1. Business Overview
    10.5.2. Company Basic Information
    10.5.3. DNA Vaccine Product Details
    10.5.4. Astellas Pharma DNA Vaccine Production, Revenue and Gross Margin
    10.6. MERCK & CO.
    10.6.1. Business Overview
    10.6.2. Company Basic Information
    10.6.3. DNA Vaccine Product Details
    10.6.4. Merck & Co. DNA Vaccine Production, Revenue and Gross Margin
    10.7. GLAXOSMITHKLINE INC.
    10.7.1. Business Overview
    10.7.2. Company Basic Information
    10.7.3. DNA Vaccine Product Details
    10.7.4. GlaxoSmithKline Inc. DNA Vaccine Production, Revenue and Gross Margin
    10.8. SANOFI
    10.8.1. Business Overview
    10.8.2. Company Basic Information
    10.8.3. DNA Vaccine Product Details
    10.8.4. Sanofi DNA Vaccine Production, Revenue and Gross Margin
    10.9. XENETIC BIOSCIENCES INC.
    10.9.1. Business Overview
    10.9.2. Company Basic Information
    10.9.3. DNA Vaccine Product Details
    10.9.4. Xenetic Biosciences Inc. DNA Vaccine Production, Revenue and Gross Margin
    10.10. TEKMIRA PHARMACEUTICALS
    10.10.1. Business Overview
    10.10.2. Company Basic Information
    10.10.3. DNA Vaccine Product Details
    10.10.4. Tekmira Pharmaceuticals DNA Vaccine Production, Revenue and Gross Margin
    CHAPTER 11. DNA VACCINE MARKET VALUE CHAIN ANALYSIS
    11.1. DNA VACCINE INDUSTRIAL CHAIN ANALYSIS
    11.2. DNA VACCINE KEY RAW MATERIALS ANALYSIS
    11.2.1. Key Raw Materials
    11.2.2. Price Trend of Key Raw Materials
    11.2.3. Key Suppliers of Raw Materials

    keyboard_arrow_up
  • •Vical Inc.
    •Novartis Animal Health
    •Inovio Biomedical Corp.
    •Dendreon Corporation
    •Astellas Pharma
    •Merck & Co.
    •GlaxoSmithKline Inc.
    •Sanofi
    •Xenetic Biosciences Inc.
    •Tekmira Pharmaceuticals
    •Indian Immunologicals Ltd
    •Pfizer Pharmaceuticals
    •Tolerion Inc.
    •QED Biosciences Inc.
    •Advance Bioscience Laboratories Inc.

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the DNA Vaccine Market in 2016 and the expected market size by 2024, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions and their comparative growth rate?
• Which technology is in trend and how would it evolve during the forecast period (2016 – 2024)?
• Which are the leading companies in the DNA Vaccine Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

CLIENTS